Director of Partnerships
SweedFull Time
Expert & Leadership (9+ years)
Candidates must possess an advanced degree (PhD, MD, or MBA) in life sciences or a related field, with over 10 years of experience in clinical business development, ideally within the proteomics, diagnostics, or biotech sectors. A customer-centric approach, a proven history of closing strategic deals and managing complex partnerships, and a deep understanding of clinical trial design, biomarker validation, and regulatory frameworks are essential. Excellent communication, negotiation, and leadership skills are also required, along with innovative thinking and the ability to identify new growth opportunities.
The Sr. Director, Clinical Business Development will lead strategic partnerships and commercial initiatives for Alamar's proteomics platform, focusing on clinical applications. This includes identifying, negotiating, and managing clinical collaborations and licensing opportunities, as well as developing and executing strategies for market expansion in clinical diagnostics and translational research. The role involves collaborating with R&D, regulatory, and commercial teams, engaging with key opinion leaders and decision-makers, providing input on clinical validation and regulatory pathways, and driving revenue growth through partnerships and co-development deals.
Develops technology for protein detection and measurement
Alamar Biosciences focuses on the study of proteins, known as proteomics, to enhance disease detection and treatment. The company has created NULISA™, a technology that can detect and measure proteins in the human body with high sensitivity and a wide range. This allows researchers and clinicians to profile clinically relevant protein biomarkers, which are essential for developing new diagnostic tests and treatments for various diseases. Alamar's ARGO™ system complements NULISA™ by providing a fully automated, high-throughput platform for precision proteomics. Unlike competitors, Alamar's technology simplifies the process, reducing the need for extensive technical expertise, making it more accessible to clients. The goal of Alamar Biosciences is to improve our understanding of proteins in health and disease, ultimately leading to better early detection and treatment options.